Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

Shipley, W U; Winter, K A; Kaufman, D S; Lee, W R; Heney, N M; Tester, W R; Donnelly, B J; Venner, P M; Perez, C A; Murray, K J; Doggett, R S; True, L D

Shipley, W U; Winter, K A; Kaufman, D S; Lee, W R; Heney, N M; Tester, W R; Donnelly, B J; Venner, P M; Perez, C A; Murray, K J; Doggett, R S; True, L D.

Affiliation

Shipley WU; Department of Radiation Oncology, Massachusetts General Hospital, Boston 02114, USA.

J Clin Oncol ; 16(11): 3576-83, 1998 Nov.

Article in En | MEDLINE | ID: mdl-9817278

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/radiotherapy; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Chemotherapy, Adjuvant; Cisplatin/administration & dosage; Combined Modality Therapy; Female; Hematologic Diseases/chemically induced; Humans; Male; Methotrexate/administration & dosage; Middle Aged; Nausea/chemically induced; Neoplasm Invasiveness; Survival Analysis; Time Factors; Vinblastine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links